Kimberley Doucette MD

Hematologic Oncology

Physician

3800 Reservoir Rd NWWashington, DC 20007
Phone+1 202-444-3736
Fax+1 202-444-0939

Dr. Doucette is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Doucette's full profile Already have an account?

Education & Training

St. George's University School of MedicineClass of 2015

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

DC State Medical License 2018 - 2028
VA State Medical License 2023 - 2028
NJ State Medical License 2024 - 2027
MD State Medical License 2021 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Characterization and prognostic implications of infections associated with T-cell engagers in multiple myeloma.
Lindsay Fogel, Harsh Parmar, Shucen Wan, Pooja Phull, Kimberly Doucette
Leukemia & Lymphoma. 2026-08-11
Consolidation Therapy with Checkpoint Inhibitors After Autologous Hematopoietic Cell Transplantation in Patients with High-Risk Multiple Myeloma and Lymphoma.
Lindsay Fogel, Patrick C Roney, Jaeil Ahn, Joshua Zenreich, Adolfo Aleman
Transplantation and Cellular Therapy. 2026-05-14
3 citations
Inotuzumab Ozogamicin Then Blinatumomab for Older Adults With Newly Diagnosed B-Cell ALL: Alliance Study A041703 Cohort 1 Results.
Matthew J Wieduwilt, Jun Yin, Oudom Kour, Rebecca Teske, Wendy Stock
Journal of Clinical Oncology. 2025-11-10

Abstracts/Posters

The Impact of Diagnosis to Treatment Interval on the Outcome of Patients with Acute Myeloid Leukemia
Kimberley Doucette, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

Recent Advancements and Future Directions in Frontline Treatment of Multiple MyelomaJuly 11th, 2022
Genetics of Donor Cell Leukemia in Acute Myelogenous Leukemia and Myelodysplastic SyndromeMarch 8th, 2021